SCHEMBL1814739

SCHEMBL1814739

C=CC(N)SS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7285763 0.72
SCHEMBL1814736 0.72
SCHEMBL18396189 0.67
SCHEMBL1176679 0.67
SCHEMBL3731468 0.65
SCHEMBL252880 0.62
SCHEMBL899543 0.61
SCHEMBL87668 0.60
SCHEMBL8541370 0.60
SCHEMBL8985771 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115724779-B Amide alkyl disulfide compound, preparation method and application thereof 四川大学 2024-03-29 CN claimed
CN-115724779-A Amidoalkane disulfide compound, preparation method and application thereof 四川大学 2023-03-03 CN claimed
CN-109348716-A [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors 豪夫迈·罗氏有限公司 2019-02-15 CN claimed
CN-109311886-A Novel [1,2,3] triazol [4,5-d] pyrimidine derivatives 豪夫迈·罗氏有限公司 2019-02-05 CN claimed
CN-115724779-B Amide alkyl disulfide compound, preparation method and application thereof 四川大学 2024-03-29 CN disclosed
CN-115724779-A Amidoalkane disulfide compound, preparation method and application thereof 四川大学 2023-03-03 CN disclosed
CN-109348716-A [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors 豪夫迈·罗氏有限公司 2019-02-15 CN disclosed
CN-109311886-A Novel [1,2,3] triazol [4,5-d] pyrimidine derivatives 豪夫迈·罗氏有限公司 2019-02-05 CN disclosed
EP-2319542-B1 Segmented degradable polymers and conjugates made therefrom NEKTAR THERAPEUTICS (US) 2018-03-21 EP disclosed
EP-1986695-B1 SEGMENTED DEGRADABLE POLYMERS AND CONJUGATES MADE THEREFROM NEKTAR THERAPEUTICS (US) 2015-06-03 EP disclosed
US-8835599-B2 Segmented degradable polymers and conjugates made therefrom NEKTAR THERAPEUTICS (US) 2014-09-16 US disclosed
US-20130072709-A1 Segmented Degradable Polymers and Conjugates Made Therefrom NEKTAR THERAPEUTICS (US) 2013-03-21 US disclosed
US-6344523-B1 POLYIMIDES COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION OF CAMPBELL (AU) 2002-02-05 US disclosed
EP-0966493-A1 REDUCED TEMPERATURE CURING OF ACETYLENIC POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 1999-12-29 EP disclosed
WO-1998040422-A1 REDUCED TEMPERATURE CURING OF ACETYLENIC POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 1998-09-17 WO disclosed
EP-0504321-B1 ENHANCED CAPTURE OF TARGET NUCLEIC ACID BY THE USE OF OLIGONUCLEOTIDES COVALENTLY ATTACHED TO POLYMERS MICROPROBE CORP (US) 1997-05-07 EP disclosed
EP-0504321-A4 ENHANCED CAPTURE OF TARGET NUCLEIC ACID BY THE USE OF OLIGONUCLEOTIDES COVALENTLY ATTACHED TO POLYMERS 1993-07-14 EP disclosed
EP-0504321-A1 ENHANCED CAPTURE OF TARGET NUCLEIC ACID BY THE USE OF OLIGONUCLEOTIDES COVALENTLY ATTACHED TO POLYMERS. MICROPROBE CORP (US) 1992-09-23 EP disclosed
WO-1991008307-A1 ENHANCED CAPTURE OF TARGET NUCLEIC ACID BY THE USE OF OLIGONUCLEOTIDES COVALENTLY ATTACHED TO POLYMERS MICROPROBE CORPORATION (US) 1991-06-13 WO disclosed
WO-1990001564-A1 METHODS FOR MULTIPLE TARGET ANALYSES THROUGH NUCLEIC ACID HYBRIDIZATION MICROPROBE CORPORATION (US) 1990-02-22 WO disclosed